Proanthocyanidins as Therapeutic Agents in Inflammation-Related Skin Disorders

Area of Science:

• Dermatology
• Pharmacology
• Natural Products Chemistry

Background:

• Skin diseases affect a significant portion of the global population, presenting complex challenges in treatment.
• Current therapies for impaired wound healing and chronic inflammatory skin conditions like psoriasis and atopic dermatitis are often insufficient.
• Phytotherapeutics, particularly proanthocyanidins (PACs), are emerging as promising natural compounds for dermatological applications.

Purpose of the Study:

• To review the biomolecular mechanisms, pharmacological effects, and phytochemical properties of PACs over the past 25 years.
• To evaluate the potential of PACs in treating inflammatory skin diseases and impaired wound healing.
• To identify knowledge gaps and future research directions for PACs in dermatologic therapy.

Main Methods:

• Comprehensive literature review of research on proanthocyanidins (PACs) in skin health over the last 25 years.
• Analysis of preclinical data on the anti-inflammatory, antioxidant, pro-regenerative, and pro-angiogenic effects of PACs.
• Examination of PACs' role in wound healing, chronic inflammatory disorders, and photoprotection.

Main Results:

• PACs demonstrate pro-regenerative, pro-angiogenic, antioxidant, and anti-inflammatory effects beneficial for wound closure.
• Preclinical studies indicate PACs can effectively mitigate inflammatory skin conditions such as psoriasis and atopic dermatitis.
• PACs exhibit photoprotective properties, potentially preventing UV-induced skin inflammation.

Conclusions:

• PACs hold significant promise as therapeutic agents for inflammatory skin diseases and impaired wound healing.
• Further clinical validation and research into structure-activity relationships are crucial for optimizing PACs' dermatologic use.
• Development of advanced topical formulations is necessary to enhance the efficacy of PACs in dermatological treatments.